4 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
ERA-NET on cardiovascular diseases to implement joint transnational research projects and set up international cooperations (ERA-CVD)
Date du début: 1 oct. 2015, Date de fin: 30 sept. 2020,
Cardiovascular diseases (CVD) are the largest cause of death in the EU and account for around 2 million deaths per year. Overall, CVD are estimated to cause the economy of the EU costs of almost 196 billion Euros a year. Furthermore, they are one of the leading causes of long term sickness, chronic diseases and loss to the labour market. Therefore, CVD are a major health problem in Europe. Despite ...
Voir le projet
23
Participants partenaires
TERMINÉ
Bridging Patient Summaries across the Atlantic (Trillium Bridge)
Date du début: 1 juil. 2013, Date de fin: 30 juin 2015,
Description
Bridging Patient Summaries across the Atlantic
What if you, while visiting the US, need urgent medical help and the doctor doesn't know your medical history? The Trillium Bridge project wants to align the use of standards between the EU and the US to share basic patient data between EU ...
Voir le projet
13
Participants partenaires
TERMINÉ
"Harmonizing, Integrating and Vitalizing European Research on hiv/Aids" (HIVERA)
Date du début: 1 mai 2010, Date de fin: 30 avr. 2015,
"HIV infection is a major worldwide epidemic threatening public health in all affected countries. Although a wide range of financial support has been successfully dedicated to HIV through national and/or EC-funded programmes, there is still little cooperation between national funding programmes in Europe, while this field is highly international, operationally as well as competitively, in all disc ...
Voir le projet
16
Participants partenaires
TERMINÉ
ERA-Net on Rare Diseases (E-Rare-2)
Date du début: 1 oct. 2010, Date de fin: 30 nov. 2014,
Rare diseases represent an important public-health issue, affecting 26-30 million persons across Europe, and a major challenge for research. The fragmentation of resources and knowledge for the 6000-8000 rare diseases and the lack of treatment for the majority of them necessitate a coordinated European approach to unravel the underlying molecular defects and pathophysiological mechanisms. The low ...
Voir le projet